The mechanisms that enable preservation of gut mucosal integrity during persistent viral replication and inherent inflammation remain unclear. Here, we investigated, for the first time, gut ...

A study shows that HIV-2 is more pathogenic than previously demonstrated. The new findings indicate that early treatment should be applied to all patients with HIV, not only to those with HIV-1. A ...

"Gilead’s HIV ART combo deemed non-inferior in second Phase III trial" was originally created and published by Clinical ...

Progressive immune dysfunction and the acquired immunodeficiency syndrome (AIDS) develop in most persons with untreated infection with human immunodeficiency virus type 1 (HIV-1) but in only ...

Gilead Sciences, Inc. GILD announced that the investigational single-tablet regimen of bictegravir and lenacapavir for the ...

According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million ...

Within half a century, the world has experienced two elusive and deadly viral diseases responsible for pandemics. While there are many similarities between the ongoing HIV pandemic and the current ...

Researchers have identified a new HIV strain, the first discovered in nearly 20 years. In a study published Wednesday in the peer-reviewed Journal of Acquired Immune Deficiency Syndromes, a group of ...

This retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory. Objectives: To understand real-world implementation of the updated CDC HIV ...

A 53-year-old from Düsseldorf in Germany has become the third person in the world to be completely cured of HIV following a stem cell transplant using donor cells with a particular genetic mutation.

Federal health officials have approved the first at-home test to detect HIV antibodies, a move aimed at identifying and treating the estimated 20 percent of infected people in the U.S. who don’t know ...